PDF herunterladen
Erfahrungsheilkunde 2021; 70(05): 280-286
DOI: 10.1055/a-1585-9151
Praxis

Wie man mit der Ernährung Einfluss auf Fettstoffwechselstörungen nehmen kann

Petra Römmele
› Weitere Informationen
    Lizenzen und Reprints

Zusammenfassung

Mit einer Änderung der Ernährungsgewohnheiten können Lipoproteinämien positiv beeinflusst werden. Dabei gilt es, auf eine ausgeglichene Energiebilanz zu achten, Übergewicht zu reduzieren sowie die Zufuhr einzelner Nährstoffe über eine veränderte Lebensmittelauswahl anzupassen. Eine pflanzenreiche Ernährung, reich an Pflanzenölen, fermentierten Milchprodukten und Vollkornprodukten, bei gleichzeitig geringem Konsum von fettem Fleisch und Zucker, ist vorteilhaft. Funktionelle Lebensmittel können ergänzend verwendet werden. Ernährungsformen wie die mediterrane Ernährung oder die DASH-Diät vereinen wichtige Prinzipien der Ernährung bei Lipoproteinämien und können eine gute Basis einer veränderten Ernährungsweise sein.

Abstract

Dyslipidemia can be positively influenced by changing nutritional habits. A balanced energy intake and the reduction of overweight are important. By adjusting the choice of foods, the supply of individual nutrients shall be changed. A nutrition rich in vegetables, vegetable oils, fermented milk products and whole grain products with a low consumption of streaky fatty meat and sugar is advantageous. Functional foods can complete the approach. The Mediterranean or DASH diet’s eating patterns include these important principles for the nutrition and can be a good base of changed eating habits in case of dyslipidemia.

Schlüsselwörter

Fettstoffwechselstörung - Ernährung - Ernährungsformen - Cholesterin - gesättigte Fettsäuren - funktionelle Lebensmittel

Key words

Dyslipidemia - Nutrition - eating pattern - Cholesterol - saturated fatty acids - functional foods


Publikationsverlauf

Artikel online veröffentlicht:
12. Oktober 2021

© 2021. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • Literatur

  • 1 Appel LJ, Sacks FM, Carey VJ. et al. Effects of Protein, monounsaturated fat, and carbohydrate intake on blood pressure and serum lipids: Results of the omniheart randomized trial. JAMA 2005; 294 (19) 2455-2464
    CrossrefPubMedGoogle Scholar
  • 2 Cicero A, Colletti A, Bajraktari G. et al. Lipid-lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel. Nutr Rev 2017; 75 (09) 731-767
    CrossrefPubMedGoogle Scholar
  • 3 Mach F, Baigent C, Catapano AL. et al. ESC Scientific Document Group, 2019 ESC/EAS Guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk. The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS). Eur Heart J 2020; 41 (01) 111-188
    CrossrefPubMedGoogle Scholar
  • 4 Schoeneck M, Iggman D. The effects of foods on LDL cholesterol levels: A systematic review of the accumulated evidence from systematic reviews and meta-analyses of randomized controlled trials. Nutr Metab Cardiovasc Dis 2021; 31: 1325-1338
    CrossrefPubMedGoogle Scholar
  • 5 Zomer E, Gurusamy K, Leach R. et al. Interventions that cause weight loss and the impact on cardiovascular risk factors: a systematic review and meta-analysis. Obesity Rev 2016; 17 (10) 1001-1011
    CrossrefPubMedGoogle Scholar
  • 6 Nordmann AJ, Nordmann A, Briel M. et al. Effects of low-carbohydrate vs low-fat diets on weight loss and cardiovascular risk factors: A meta-analysis of randomized controlled trials. Arch Int Med 2006; 166 (03) 285-293
    CrossrefPubMedGoogle Scholar
  • 7 Deutsche Gesellschaft für Ernährung. Hrsg. DGE Beratungsstandards. Bonn: DGE; 2020
    Google Scholar
  • 8 Yu-Poth S, Zhao G, Etherton T. et al. Effects of the National Cholesterol Education Program’s step I and step II dietary intervention programs on cardiovascular disease risk factors: a meta-analysis. Am J Clin Nutr 1999; 69 (04) 632-646
    CrossrefPubMedGoogle Scholar
  • 9 Lefevre M, Champagne CM, Tulley RT. et al. Individual variability in cardiovascular disease risk factor responses to low-fat and low-saturated-fat diets in men: body mass index, adiposity, and insulin resistance predict changes in LDL cholesterol. Am J Clin Nutr 2005; 82: 957-963
    CrossrefPubMedGoogle Scholar
  • 10 de Lorgeril M, Salen P, Martin JL. et al. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study. Circulation 1999; 99 (06) 779-785
    CrossrefPubMedGoogle Scholar
  • 11 Estruch R, Ros E, Salas-Salvadó J. et al. PREDIMED study investigators: primary prevention of cardiovascular disease with a mediterranean diet supplemented with extra-virgin olive oil or nuts. New Engl J Med 2018; 378 (25) e34
    CrossrefPubMedGoogle Scholar
  • 12 Briggs MA, Petersen KS, Kris-Etherton PM. Saturated fatty acids and cardiovascular disease: replacements for saturated fat to reduce cardiovascular risk. Healthcare 2017; 5 (02) 29
    CrossrefPubMedGoogle Scholar
  • 13 Mensink RP. Effects of saturated fatty acids on serum lipids and lipoproteins: a systematic review and regression analysis. Genf: World Health Organization; 2016
    Google Scholar
  • 14 Hooper L, Martin N, Jimoh OF. et al. Reduction in saturated fat intake for cardiovascular disease. Coch Data Syst Rev 2020; 5 (05) CD011737
    PubMedGoogle Scholar
  • 15 Astrup A, Magkos F, Bier D. et al. Saturated fats and health: A reassessment and proposal for food-based recommendations. Jacc state-of-the-art review. J Am Coll Cardiol 2005; 76 (07) 844-857
    CrossrefPubMedGoogle Scholar
  • 16 Formisano E, Pasta A, Cremonini AL. et al. Effects of a mediterranean diet, dairy, and meat products on different phenotypes of dyslipidemia: A preliminary retrospective analysis. Nutrients 2021; 13 (04) 1161
    CrossrefPubMedGoogle Scholar
  • 17 Mozaffarian D, Aro A, Willett WC. Health effects of trans-fatty acids: experimental and observational evidence. Eur J Clin Nutr 2009; 63 (02) 5-21
    CrossrefPubMedGoogle Scholar
  • 18 World Health Organization. Brouwer IA. Effect of trans-fatty acid intake on blood lipids and lipoproteins: A systematic review and meta-regression analysis. World Health Organization; 2016. Im Internet: https://apps.who.int/iris/handle/10665/246109 (Stand: 20.09.2021)
    Google Scholar
  • 19 Deutsche Gesellschaft für Ernährung. Hrsg. Evidenzbasierte Leitlinie: Fettkonsum und Prävention ausgewählter ernährungsbedingter Krankheiten. Bonn: DGE; 2015
    Google Scholar
  • 20 Berger S, Raman G, Vishwanathan S. et al. Dietary cholesterol and cardiovascular disease: a systematic review and meta-analysis. Am J Clin Nutr 2015; 102 (02) 276-294
    CrossrefPubMedGoogle Scholar
  • 21 Griffin JD, Lichtenstein AH. Dietary cholesterol and plasma lipoprotein profiles: Randomized-controlled trials. Curr Nutr Rep 2013; 2 (04) 274-282
    CrossrefPubMedGoogle Scholar
  • 22 Brown L, Rosner B, Willett WW. et al. Cholesterol-lowering effects of dietary fiber: a meta-analysis. Am J Clin Nutr 1999; 69 (01) 30-42
    CrossrefPubMedGoogle Scholar
  • 23 Hartley L, May MD, Loveman E. et al. Dietary fibre for the primary prevention of cardiovascular disease. Coch Data Syst Rev 2016; 1: CD011472
    PubMedGoogle Scholar
  • 24 Threapleton DE, Greenwood DC, Evans CE. et al. Dietary fibre intake and risk of cardiovascular disease: Systematic review and meta-analysis. BMJ 2013; 347: f6879
    CrossrefPubMedGoogle Scholar
  • 25 Musa-Veloso K, Poon TH, Elliot JA. et al. A comparison of the LDL cholesterol lowering efficacy of plant stanols and plant sterols over a continuous dose range: Results of a meta-analysis of randomized, placebo-controlled trials. Prostagl Leukot Ess Fatty Acids 2011; 85: 9-28
    CrossrefPubMedGoogle Scholar
  • 26 Ras RT, Hiemstra H, Lin Y. et al. Consumption of plant sterol-enriched foods and effects on plasma plant sterol concentrations – a meta-analysis of randomized controlled studies. Atherosclerosis 2013; 230 (02) 336-346
    CrossrefPubMedGoogle Scholar
  • 27 Kłosiewicz-Latoszek L, Cybulska B, Stoś K. et al. Hypolipaemic nutraceutics: red yeast rice and armolipid, berberine and bergamot. AAEM 2021; 28 (01) 81-88
    PubMedGoogle Scholar
  • 28 Bundesinstitut für Risikobewertung. Cholesterinsenkung mit Folgen: Nahrungsergänzungsmittel mit Rotschimmelreis nur nach ärztlicher Rücksprache einnehmen. Im Internet: https://www.bfr.bund.de/cm/343/cholesterinsen​kung-mit-folgen-nahrungsergaenzungsmittel-mit-rotschim​melreis-nur-nach-aerztlicher-ruecksprache-einnehmen.pdf (Stand: 20.09.2021)
    PubMedGoogle Scholar
  • 29 Bessembinders K, Wielders J, van de Wiel A. Severe hypertriglyceridemia influenced by alcohol (SHIBA). Alc Alcoholism 2011; 46 (02) 113-116
    CrossrefPubMedGoogle Scholar
  • 30 de Natale C, Annuzzi G, Bozzetto L. et al. Effects of a plant-based high-carbohydrate/high-fiber diet versus high-monounsaturated fat/low-carbohydrate diet on postprandial lipids in type 2 diabetic patients. Diab Care 2009; 32 (12) 2168-2173
    CrossrefPubMedGoogle Scholar
  • 31 Cao Y, Mauger DT, Pelkman CL. et al. Effects of moderate (MF) versus lower fat (LF) diets on lipids and lipoproteins: a meta-analysis of clinical trials in subjects with and without diabetes. J Clin Lipidol 2009; 3 (01) 19-32
    CrossrefPubMedGoogle Scholar
  • 32 Salas-Salvadó J, Fernández-Ballart J, Ros E. et al. PREDIMED study investigators. Effect of a mediterranean diet supplemented with nuts on metabolic syndrome status: one-year results of the PREDIMED randomized trial. Arch Int Med 2008; 168: 2449-2458
    CrossrefPubMedGoogle Scholar
  • 33 Bhatt DL, Steg G, Miller M. et al. for the REDUCE-IT Investigators. Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia. N Engl J Med 2019; 380: 11-22
    CrossrefPubMedGoogle Scholar
  • 34 Skulas-Ray AC, Wilson P, Harris WS. et al. American Heart Association Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Lifestyle and Cardiometabolic Health; Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; and Council on Clinical Cardiology. Omega-3 fatty acids for the management of hypertriglyceridemia: A science advisory from the American Heart Association. Circulation 2019; 140 (12) e673-e691
    PubMedGoogle Scholar
  • 35 Hu Y, Hu FB, Manson JE. Marine Omega-3 supplementation and cardiovascular disease: An updated meta-analysis of 13 randomized controlled trials involving 127477 participants. J Am Heart Assoc 2019; 8 (19) e013543
    CrossrefPubMedGoogle Scholar
  • 36 Basu A, Rhone M, Lyons TJ. Berries: Emerging impact on cardiovascular health. Nutr Rev 2010; 68: 168-177
    CrossrefPubMedGoogle Scholar
  • 37 Onakpoya IJ, Spencer E, Heneghan C. et al. The effect of green tea on blood pressure and lipid profile: A systematic review and meta-analysis of randomized clinical trials. Nutr Metab Cardiovasc Dis 2014; 24: 823-836
    CrossrefPubMedGoogle Scholar
  • 38 Tokede OA, Onabanjo TA, Yansane A. et al. Soya products and serum lipids: A meta-analysis of randomised controlled trials. Br J Nutr 2015; 114: 831-843
    CrossrefPubMedGoogle Scholar
  • 39 Sarriá B, Martínez-López S, Sierra-Cinos JL. et al. Regular consumption of a cocoa product improves the cardiometabolic profile in healthy and moderately hypercholesterolaemic adults. Br J Nutr 2013; 111: 122-134
    CrossrefPubMedGoogle Scholar
  • 40 Appel LJ, Moore TJ, Obarzanek E. et al. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med 1997; 336 (16) 1117-1124
    CrossrefPubMedGoogle Scholar
  • 41 Sacks FM, Obarzanek E, Windhauser MM. et al. Rationale and design of the dietary approaches to stop hypertension trial (DASH). A multicenter controlled-feeding study of dietary patterns to lower blood pressure. Ann Epidemiol 1995; 5 (02) 108-118
    CrossrefPubMedGoogle Scholar
  • 42 Bach-Faig A, Berry EM, Lairon D. et al. Mediterranean Diet Foundation Expert Group. Mediterranean diet pyramid today. Science and cultural updates. Publ Health Nutr 2011; 12(A): 2274-2284
    CrossrefPubMedGoogle Scholar